Belite Bio, Inc Selling, General and Administrative Expense
Belite Bio, Inc (BLTE) reported Selling, General and Administrative Expense of $38.83 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-03-31
| Period end | Selling, General and Administrative Expense 12 month |
|---|---|
| 2025-12-31 | $38.83M 20-F · filed 2026-03-31 |
| 2024-12-31 | $10.06M 20-F · filed 2026-03-31 |
| 2023-12-31 | $6.82M 20-F · filed 2026-03-31 |